Form 4: Vita Coco CEO Sells Shares Under 10b5-1 Plan

Vita Coco Company CEO Martin Roper and related family trusts sold a total of 40,000 shares of common stock in early October 2025 under a pre-arranged 10b5-1 trading plan.

Summary

• Martin Roper, CEO and Director of Vita Coco Company, Inc. (COCO), reported sales of common stock on October 1 and October 2, 2025.
• A total of 40,000 shares were sold across these two days, executed pursuant to a Rule 10b5-1 trading plan.
• Direct sales by Martin Roper totaled 10,000 shares, with 5,000 shares sold on October 1, 2025, at a weighted average price of $42.457, and 5,000 shares sold on October 2, 2025, at a weighted average price of $42.067.
• Indirect sales by the Christopher G. Roper Exempt Family Trust totaled 10,000 shares, sold at weighted average prices of $42.463 and $42.049 on October 1 and October 2, 2025, respectively.
• Indirect sales by the Peter S. Roper Exempt Family Trust totaled 10,000 shares, sold at weighted average prices of $42.458 and $42.066 on October 1 and October 2, 2025, respectively.
• Indirect sales by the Thomas L. Roper Exempt Family Trust totaled 10,000 shares, sold at weighted average prices of $42.467 and $42.069 on October 1 and October 2, 2025, respectively.
• Following these transactions, Martin Roper directly beneficially owns 298,897 shares of common stock.
• Indirect beneficial ownership includes 233,406 shares held by the Christopher G. Roper Exempt Family Trust, 232,515 shares by the Peter S. Roper Exempt Family Trust, 233,531 shares by the Thomas L. Roper Exempt Family Trust, and 61,200 shares by spouse.
• Martin Roper also holds various Non-Qualified Stock Options totaling 1,048,460 derivative securities, with exercise prices ranging from $10.178 to $32.78 and various vesting schedules and expiration dates.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, which indicates these are routine, planned transactions rather than a reaction to new, adverse information. While insider selling can sometimes be perceived negatively, the existence of the 10b5-1 plan mitigates this concern, suggesting no immediate change in the insider's outlook on the company's prospects. The CEO retains substantial equity holdings.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned divestment strategy rather than a reaction to new, undisclosed negative information.
• The reporting person retains significant direct and indirect beneficial ownership of common stock (over 825,000 shares) and substantial derivative securities (over 1 million options), aligning interests with shareholders.

Negatives

• Insider selling, even if planned, can sometimes be perceived negatively by the market, potentially signaling that the insider believes the stock price is at a favorable level for selling.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Sales of 10,000 shares of common stock by the Christopher G. Roper Exempt Family Trust.
• Sales of 10,000 shares of common stock by the Peter S. Roper Exempt Family Trust.
• Sales of 10,000 shares of common stock by the Thomas L. Roper Exempt Family Trust.
• Indirect beneficial ownership of 61,200 shares by spouse.

Stakeholder Impact

• Shareholders: May interpret the insider selling, even if planned, as a signal regarding the stock's valuation, potentially leading to short-term price fluctuations. However, the 10b5-1 plan context suggests a pre-determined financial planning move rather than a change in company outlook.
• Management/Employees: No direct impact on management or employees is mentioned, but general market perception of insider transactions can indirectly affect morale or confidence.

Next Steps

• The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the reported ranges upon request to the Issuer, security holders, or the SEC staff.
• Future vesting of Non-Qualified Stock Options will occur in annual installments beginning on March 4, 2025, and March 3, 2026, for specific option grants.

Key Dates

Recommendation

The transactions represent planned sales under a Rule 10b5-1 trading plan, which are pre-scheduled and do not necessarily reflect a change in the insider's view of the company's future prospects. While insider selling can sometimes be a negative signal, the planned nature of these sales mitigates that concern. The CEO retains significant equity and derivative holdings. Therefore, a 'hold' recommendation is appropriate as these transactions are routine and do not provide new fundamental insights to warrant a change in investment thesis.

Keywords

Vita Coco Company, COCO, Martin Roper, Insider Trading, SEC Form 4, Stock Sale, 10b5-1 Plan, CEO, Director, Equity Sales, Coconut Water